Online Inquiry
Deferiprone
Cat. No. IC23038
CAS. No. 30652-11-0
Key Features and Details
Category
Inhibitor&Activator
Purity
99.52%
Formula
C7H9NO2
Product Details
Product Name
Deferiprone
CAS No.
30652-11-0
Molecular Weight
139.15
Formula
C7H9NO2
Appearance
Solid
Purity
99.52%
SMILES
O=C1C(O)=C(C)N(C)C=C1
Product Overview
Description
Deferiprone is the only orally active iron-chelating drug to be used therapeutically in conditions of transfusional iron overload. Target：Deferiprone is an orphan drug designed and developed primarily by academic initiatives for the treatment of iron overload in thalassaemia. Deferiprone has been used in several other iron or other metal imbalance conditions and has prospects of wider clinical applications. Deferiprone has high affinity for iron and interacts with almost all the iron pools at the molecular, cellular, tissue and organ levels. Doses of 50-120 mg/kg/day appear to be effective in bringing patients to negative iron balance. Deferiprone increases urinary iron excretion, which mainly depends on the iron load of patients and the dose of the drug.
Storage & Handling
Storage
Powder, -20 °C, 3 years; 4 °C, 2 years
In solvent: -80 °C, 6 months, -20 °C, 1 month.
Shipping
Room temperature in continental US; may vary elsewhere.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Related Products